Clinical Trials Directory

Trials / Unknown

UnknownNCT03506763

Effect of Pre-medication in Pain Measures on Office Hysteroscopy

Effect of Pre-medication in Pain Measures on Office Hysteroscopy - Randomized Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
231 (estimated)
Sponsor
Hospital de Clinicas de Porto Alegre · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Will be perform a RCT to compare pain measure on office hysteroscopy after pre-medication with oral analgesic. Patients will be alocate to oral sodic diclofenac, scopolamin or placebo. We will compare visual analog score of pain after the procedure. Patients: patients with indication of office hysteroscopy to evaluate uterine intracavitary abnormality. Interventions Group 1 (control) The patients will receive about 2 h prior to the procedure 2 placebo tablets. Group 2 (diclofenac + scopolamine) The patients will receive about 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of scopolamine 2 mg. Group 3 (diclofenac only). Patients will receive approximately 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of placebo.

Detailed description

Pain during and 30 minutes after a hysteroscopy will be measured through the visual analog pain scale of 10 centimeters, considering 0 (no pain) and 10 (unbearable pain or the greatest pain ever experienced). Acceptance of the procedure and assessed through the Likert 5-point scale: 1) totally disagree; 2) disagree; 3) I do not agree or disagree; 4) I agree and 5) I totally agree.There will also be a need for analgesia after the procedure, the time spent in the observation room and the onset of vagal symptoms such as dizziness, malaise, nausea, vomiting or syncope

Conditions

Interventions

TypeNameDescription
DRUGPlacebo Oral + Placebo OralPlacebo Oral + Placebo Oral
DRUGDiclofenac oral + Placebo OralDiclofenac oral + Placebo Oral
DRUGDiclofenac oral + scopolamina oralDiclofenac oral + scopolamina oral

Timeline

Start date
2017-08-01
Primary completion
2018-12-31
Completion
2019-06-30
First posted
2018-04-24
Last updated
2018-04-24

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03506763. Inclusion in this directory is not an endorsement.